Mitu Ovidiu, Roca Mihai, Floria Mariana, Petris Antoniu Octavian, Graur Mariana, Mitu Florin
Gr. T. Popa University of Medicine and Pharmacy, 16 University Street, Iaşi, Romania.
Gr. T. Popa University of Medicine and Pharmacy, 16 University Street, Iaşi, Romania.
Clin Investig Arterioscler. 2017 May-Jun;29(3):111-119. doi: 10.1016/j.arteri.2016.10.004. Epub 2017 Apr 1.
The aim of this study is to evaluate the relationship and the accuracy of SCORE (Systematic Coronary Risk Evaluation Project) risk correlated to multiple methods for determining subclinical cardiovascular disease (CVD) in a healthy population.
This cross-sectional study included 120 completely asymptomatic subjects, with an age range 35-75 years, and randomly selected from the general population. The individuals were evaluated clinically and biochemical, and the SCORE risk was computed. Subclinical atherosclerosis was assessed by various methods: carotid ultrasound for intima-media thickness (cIMT) and plaque detection; aortic pulse wave velocity (aPWV); echocardiography - left ventricular mass index (LVMI) and aortic atheromatosis (AA); ankle-brachial index (ABI).
SCORE mean value was 2.95±2.71, with 76% of subjects having SCORE <5. Sixty-four percent of all subjects have had increased subclinical CVD changes, and SCORE risk score was correlated positively with all markers, except for ABI. In the multivariate analysis, increased cIMT and aPWV were significantly associated with high value of SCORE risk (OR 4.14, 95% CI: 1.42-12.15, p=0.009; respectively OR 1.41, 95% CI: 1.01-1.96, p=0.039). A positive linear relationship was observed between 3 territories of subclinical CVD (cIMT, LVMI, aPWV) and SCORE risk (p<0.0001). There was evidence of subclinical CVD in 60% of subjects with a SCORE value <5.
As most subjects with a SCORE value <5 have subclinical CVD abnormalities, a more tailored subclinical CVD primary prevention program should be encouraged.
本研究旨在评估在健康人群中,SCORE(系统性冠状动脉风险评估项目)风险与多种用于确定亚临床心血管疾病(CVD)方法之间的关系及准确性。
这项横断面研究纳入了120名完全无症状的受试者,年龄在35至75岁之间,从普通人群中随机选取。对这些个体进行临床和生化评估,并计算SCORE风险。通过多种方法评估亚临床动脉粥样硬化:颈动脉超声测量内膜中层厚度(cIMT)并检测斑块;主动脉脉搏波速度(aPWV);超声心动图测量左心室质量指数(LVMI)和主动脉粥样硬化(AA);踝臂指数(ABI)。
SCORE平均值为2.95±2.71,76%的受试者SCORE<5。所有受试者中有64%出现亚临床CVD变化增加,且SCORE风险评分与除ABI外的所有标志物呈正相关。在多变量分析中,cIMT增加和aPWV增加与SCORE风险高值显著相关(分别为OR 4.14,95%CI:1.42 - 12.15,p = 0.009;OR 1.41,95%CI:1.01 - 1.96,p = 0.039)。在亚临床CVD的三个区域(cIMT、LVMI、aPWV)与SCORE风险之间观察到正线性关系(p<0.0001)。在SCORE值<5的受试者中,60%有亚临床CVD证据。
由于大多数SCORE值<5的受试者存在亚临床CVD异常,应鼓励制定更具针对性的亚临床CVD一级预防方案。